According to a MOST announcement on February 8, the following five venture capital funds will be guided by MOST to promote the capitalization of a modern pharmaceutical industry:
• Beijing Guoli Ruihua Strategic Emerging Industry Investment Fund
• SDIC (Shanghai) Venture Capital Management Limited
• SDIC (Beijing – Tianjin – Hebei) Venture Capital Management Limited
• Shanghai Gao Tejia Investment Management Co., Ltd
• Jiangsu Ruihua Venture Capital Management Co., Ltd
The objective is to transform social capital investment into scientific and technological achievements, to promote public entrepreneurship, and to innovate national science and technology.
China Bio newss release, February 14, 2017